Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke - No Study Results Posted

Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke (ESS)

This study has been completed.

Study NCT00604630 Information provided by Max-Planck-Institute of Experimental Medicine

First Received: January 17, 2008 Last Updated: October 21, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	June 2008
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)

No publications provided by Max-Planck-Institute of Experimental Medicine

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jähnig P, Herrmann M, Knauth M, Bähr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C; EPO Stroke Trial Group. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009 Dec;40(12):e647-56. Epub 2009 Oct 15.